Document:

aph_Ex10_28

		
			Exhibit 10.28
		

		
			 
		

		
			 
		

		
			 
		

		
			 
		

		
			The CORPORATEplan for RetirementSM
		

		
			EXECUTIVE Plan
		

		
			 
		

		
			 
		

		
			 
		

		
			 
		

		
			Adoption Agreement
		

		
			 
		

		
			 
		

		
			 
		

		
			 
		

		
			 
		

		
			IMPORTANT NOTE
		

		
			 
		

		
			This document has not been approved by the Department of Labor, the Internal Revenue Service or any other governmental entity.  An Employer must determine whether the plan is subject to the Federal securities laws and the securities laws of the various states.  An Employer may not rely on this document to ensure any particular tax consequences or to ensure that the Plan is "unfunded and maintained primarily for the purpose of providing deferred compensation to a select group of management or highly compensated employees" under the Employee Retirement Income Security Act with respect to the Employer's particular situation.  Fidelity Management Trust Company, its affiliates and employees cannot and do not provide legal or tax advice or opinions in connection with this document.  This document does not constitute legal or tax advice or opinions and is not intended or written to be used, and it cannot be used by any taxpayer, for the purposes of avoiding penalties that may be imposed on the taxpayer.  This document must be reviewed by the Employer’s attorney prior to adoption. 
		

		
			
		

		
			

		 

		

			Plan Number: 44381 ECM NQ 2007 AA

		

		

			(07/2007)

		

		

			©  2007 Fidelity Management & Research Company

		

 

ADOPTION AGREEMENT
		

		
			ARTICLE 1
		

		
			 
		

		
			 
		

		
			 
		

		
			1.01PLAN INFORMATION
		

		
			 
		

		
			(a)Name of Plan:
		

		
			 
		

		
			This is the Amphenol Corporation Supplemental Defined Contribution Plan (the "Plan").
		

		
			 
		

		
			 
		

		
			1.02EMPLOYER
		

		
			 
		

		
			 
		

			
					
						(a)Employer Name:

					
					
						Amphenol Corporation

				

		
			 
		

		
			 
		

		
			(b)The term "Employer" includes the following Related Employer(s) 
		

		
			              (as defined in Section 2.01(a)(25)) participating in the Plan:    
		

		
			 
		

		
			 
		

			
					
						 

				
	
					
						Amphenol Interconnect Products Corporation

				
	
					
						Amphenol Printed Circuit, Inc.

				
	
					
						Amphenol Cable On Demand

				
	
					
						Times Fiber Communications, Inc.

				
	
					
						Sine Systems Corporation

				
	
					
						Amphenol Optimize Manufacturing Co.

				
	
					
						Amphenol T&M Antennas, Inc.

				
	
					
						Amphenol PCD, Inc.

				
	
					
						Amphenol Alden Products Company

				
	
					
						Times Microwave Systems, Inc.

				
	
					
						Amphenol Adronics, Inc.

				
	
					
						Amphenol Nelson Dunn Inc.

				
	
					
						Amphenol Tecvox LLC

				
	
					
						Amphenol Thermometrics, Inc.

				
	
					
						Amphenol EEC, Inc.

				
	
					
						FCI USA LLC

				
	
					
						Amphenol (Maryland), Inc.

				
	
					
						Piezotech, LLC

				

		
			 
		

		
			
		

		
			 
		

		
			 
		

		
			

		 

		

			Plan Number: 44381ECM NQ 2007 AA

		

		

			(07/2007)    

		

		

			

		

		

			           Page 2                                     

		

		

			          Ó 2007 Fidelity Management & Research Company

		

 

		

		
			 
		

		
			1.03COVERAGE 
		

		
			 
		

		
			(Check (a) and/or (b).)
		

		
			 
		

		
			(a)☑  The following Employees are eligible to participate in the Plan (Check (1) or (2)):
		

		
			 
		

		
			(1)   ☑Only those Employees designated in writing by the Employer, which writing is hereby incorporated herein.
		

		
			(2)   ☐Only those Employees in the eligible class described below:
		

		
			 
		

			
					
						 

					
						 

					
						 

				
	
					
						____________________________________________________________

					
						 

					
						____________________________________________________________

				

		
			 
		

		
			 
		

		
			 
		

		
			 
		

		
			(b)☐  The following Directors are eligible to participate in the Plan (Check (1) or (2)):  
		

		
			 
		

		
			(1)   ☐ Only those Directors designated in writing by the Employer, which writing is hereby incorporated herein.
		

		
			(2)   ☐  All Directors, effective as of the later of the date in 1.01(b) or the date the Director becomes a Director.
		

		
			 
		

		
			(Note:  A designation in Section 1.03(a)(1) or Section 1.03(b)(1) or a description in Section 1.03(a)(2) must include the effective date of such participation.)
		

		
			 
		

		
			 
		

		
			 
		

		
			 
		

		
			
		

		
			

		 

		

			Plan Number: 44381ECM NQ 2007 AA

		

		

			(07/2007)    

		

		

			

		

		

			           Page 3                                     

		

		

			          Ó 2007 Fidelity Management & Research Company

		

 

AMENDMENT EXECUTION PAGE
		

		
			(Fidelity’s Copy)
		

		
			 
		

		
			 
		

			
					
						 

					
					
						 

				
	
					
						Plan Name:

					
					
						Amphenol Corporation Supplemental Defined Contribution Plan (the “Plan”)

				
	
					
						Employer:

					
					
						Amphenol Corporation

				

		
			 
		

		
			(Note: These execution pages are to be completed in the event the Employer modifies any prior election(s) or makes a new election(s) in this Adoption Agreement.  Attach the amended page(s) of the Adoption Agreement to these execution pages.)
		

		
			 
		

		
			The following section(s) of the Plan are hereby amended effective as of the date(s) set forth below: 
		

		
			 
		

		
			 
		

			
					
						 

					
					
						 

				
	
					
						Section Amended

					
					
						Effective Date

				
	
					
						1.02(b)

					
					
						1/1/2019

				
	
					
						1.03(a)

					
					
						1/1/2019

				
	
					
						 

					
					
						 

				
	
					
						 

					
					
						 

				

		
			 
		

		
			 
		

		
			IN WITNESS WHEREOF, the Employer has caused this Amendment to be executed on the date below.
		

		
			 
		

		
			Employer:        Amphenol Corporation                         
		

		
			 
		

		
			By:                   /s/ David Silverman                               
		

		
			 
		

		
			Title:                Vice President, Human Resources      
		

		
			 
		

		
			Date:                December 18, 2018                               
		

		
			 
		

		
			 
		

		
			 
		

		
			

		 

		

			Plan Number: 44381ECM NQ 2007 AA

		

		

			(07/2007)    

		

		

			

		

		

			           Page 4                                     

		

		

			          Ó 2007 Fidelity Management & Research Company

		

 

 AMENDMENT EXECUTION PAGE
		

		
			(Employer’s Copy)
		

		
			 
		

		
			 
		

			
					
						Plan Name:

					
					
						Amphenol Corporation Supplemental Defined Contribution Plan (the “Plan”)

				
	
					
						Employer:

					
					
						Amphenol Corporation

				

		
			 
		

		
			(Note: These execution pages are to be completed in the event the Employer modifies any prior election(s) or makes a new election(s) in this Adoption Agreement. Attach the amended page(s) of the Adoption Agreement to these execution pages.)
		

		
			 
		

		
			 
		

			
					
						 

					
					
						 

				
	
					
						Section Amended

					
					
						Effective Date

				
	
					
						1.02(b)

					
					
						1/1/2019

				
	
					
						1.03(a)

					
					
						1/1/2019

				
	
					
						 

					
					
						 

				
	
					
						 

					
					
						 

				

		
			 
		

		
			 
		

		
			 
		

		
			IN WITNESS WHEREOF, the Employer has caused this Amendment to be executed on the date below.
		

		
			 
		

		
			 
		

		
			Employer:       Amphenol Corporation                       
		

		
			 
		

		
			By:                  /s/ David Silverman                              
		

		
			 
		

		
			Title:               Vice President, Human Resources         
		

		
			 
		

		
			Date:               December 18, 2018                              
		

		
			 
		

		
			 
		

		
			

		 

		

			Plan Number: 44381ECM NQ 2007 AA

		

		

			(07/2007)    

		

		

			

		

		

			           Page 5                                     

		

		

			          Ó 2007 Fidelity Management & Research Company

		

 

5
		

		 

		

			Plan Number: 44381ECM NQ 2007 AA

		

		

			(07/2007)    

		

		

			

		

		

			           Page 6                                     

		

		

			          Ó 2007 Fidelity Management & Research CompanyExhibit
10.1

 

Loan
Agreement

 

TTD/ABMT/L1810-01

 

	Lender:
    	TITAN
    TECHNOLOGY DEVELOPMENT LIMITED
	Address:
    	1903
    HING YIP COMMERCIAL CENTRE, 272 DES VOEUX ROAD CENTRAL, HONG KONG.
	 	(Hong
    Kong Company Registration No.: 718332)
	 	 
	Borrower:
    	ADVANCED
    BIOMEDICAL TECHNOLOGIES, INC.
	Address:
    	350
    FIFTH AVE., 59TH FLOOR, NEW YORK, NY 10118
	 	USA
    (Incorporated in the State of Nevada, USA)

 

Borrower
is the controlling shareholder of Shenzhen Changhua Biomedical Engineering Co. Ltd., approved by Shenzhen Bureau of Trade and
Industry’s permit, February 25, 2008 (2008) No. 0539 and Guangdong Shenzhen Joint Venture Permit (2008) No. 0008. Shenzhen
Changhua Biomedical Engineering Co., Ltd. is a company engaged in research and development and production of biodegradable medical
materials. Lender is a major shareholder of Borrower.

 

	1)	Loan:

 

Lender
agrees to advance to Borrower’s subsidiary Shenzhen Changhua Biomedical Engineering Co., Ltd. (Changhua) the total amount
of USD700,000 - (Seven Hundred Thousand US dollars).

 

Borrower
accepts that Lender may send the total amount in several advances using different financial institutions, associated companies
or individuals that is appointed by Lender.

 

	2)	Use
    of Proceed: For Changhua’s R&D, Clinical Trial, GMP Facilities Upgrading and Operation Expenses.
	 	 
	3)	Interest
    Rate: Annual interest rate is seven percent (7%).
	 	 
	4)	Loan
    Repayment period: 12 months
	 	 
	5)	Repayment:

 

Debt
maturity: after 12 months, Borrower will repay Lender the total amount of loan plus interest.

 

Outstanding
loan: after 6 months, Lender may demand the return of part of the loan plus interest occurred.

 

	6)	Repayment
    Methods and Repayment Source

 

Repayment
Methods: cash or securities;

 

Repayment
Source: banks and securities firms.

 

    	 

     

    

 

	7)	Warranty:

 

Borrower
and its subsidiary guarantee that the loan will be used for the purposes stipulated in this agreement and the fund may not be
used for other purposes or illegal activities;

 

Borrower
will return the loan within the terms stipulated in this agreement;

 

Borrower
and its subsidiary agree to accept the supervision of Lender on the use of proceed provided under this agreement.

 

	8)	Miscellaneous

 

This
Agreement may not be amended or modified except by a writing executed by each of the parties. Neither party shall assign (including
the engagement of subcontractors) any of its rights or obligations under this Agreement without the prior written consent of the
other party. The provisions of this Agreement, including without limitation the obligation to make loan and interest repayments,
shall be binding on Borrower, its Parent Company, its successors and assigns. All terms of this Agreement, which by their nature
extend beyond its termination, shall remain in effect until fulfilled, and shall apply to the respective successors and assigns
of the parties;

 

This
Agreement, including all controversies arising from or relating to performance under this Agreement, shall be governed by and
construed in accordance with the laws of Hong Kong, China. Venue for any action or dispute arising from or relating to this Agreement
shall conclusively lie in the Courts located in Hong Kong, China. Each party hereby waives any objection that it may have based
upon lack of personal jurisdiction, improper venue or forum non conveniens.

 

	Lender:
    	TITAN
    TECHNOLOGY DEVELOPMENT LIMITED
	 	 	 
	Signature:
    	/s/
    Chi Fung YU	 
	Name
    and Title: 	Chi
    Fung YU, Chairman	 
	 	 	 
	Borrower:
    	ADVANCED
    BIOMEDICAL TECHNOLOGIES, INC.
	 	 	 
	Signature:
    	/s/
    Hui Wang	 
	Name
    and Title: 	Hui
    Wang, Director and Chief Executive Officer	 

 

Date:
October 31, 2019

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00291-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00291-of-00352.parquet"}]]